Aimmune Therapeutics (AIMT) – Analyst Comments
-
UPDATE: Aimmune Therapeutics (AIMT) PT Cut to $18 at Stifel After Poor Responses in Allergist Survey
-
Cowen Starts Aimmune Therapeutics (AIMT) at Outperform
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to AIMT Stock Lookup